University of Toulouse
Also known as: Casselardit Hospital - University of Toulouse | Central Hospital, Toulouse, France | Centre hospitalier Rangueil | Centre hospitalier Rangueil-TOULOUSE | Centre Hospitalier Universitaire, Service de Dermatologie, Toulouse -France | Children's Hospital, Toulouse University Hospital | CHU de Toulouse - Hôpital des Enfants - Centre de Ressources et de Compétences de la Mucoviscidose (CRCM) pédiatrique | CHU de Toulouse LYSA | CHU Toulouse | CHU TOULOUSE | CHU Toulouse, France | CHU Toulouse - Hôpital La Grave - Cité de la Santé | Clinical Research Unit and Pharmacology Lab EA 3035, Institut Claudius Regaud, Toulouse, France | Clinique Pasteur Toulouse | Department of Clinical Pharmacology, Faculty of Medicine, University Hospital, Toulouse, France | Faculty of Medicine, Toulouse | Gérontopôle, CHU Toulouse | Hospital of Toulouse | Hospital University Toulouse | INSERM-University of Toulouse | Institut Claudius Régaud | Institut Claudius Regaud | Institut Claudius Regaud-IUCT Oncopôle Toulouse | Institut Claudius Regaud-TOULOUSE | Institut Claudius REGAUD - Toulouse | Institut Claudius Regaud - Toulouse - France | Institut Claudius Regaud, Toulouse, France | Institut Claudius Regaud (TOULOUSE - FRANCE) | Institut Universitaire du Cancer - Oncopole - Toulouse | Institut Universitaire du Cancer Toulouse Oncopole | Institut Universitaire du Cancer Toulouse - Oncopole | Purpan hospital, Toulouse | Purpan Hospital - UH Toulouse | Study principal Investigator Toulouse University Hospital | Toulouse University | Toulouse University Hospital | Toulouse University Hospital, France | Toulouse University Hospital / Paul Sabatier University | U H Toulouse | UH Toulouse | University Hopsital Toulouse | University Hospital Center, Toulouse | University hospital of Toulouse | University Hospital of Toulouse | University Hospital Of TOULOUSE | University Hospital of Toulouse, Hospital Pierre-Paul Riquet, Infectious & Tropical Diseases department | University Hospital of Toulouse, Hospital Pierre-Paul Riquet, Rheumatology Center | University Hospital of Toulouse, Rangueil | University Hospital of Tours | University Hospital, Toulouse | University Hospital, Toulouse, France | University Hospital Toulouse, FRANCE | University Hospital, Toulouse, France (Prof. Bruno Vellas, MD) | University Paul Sabatier of Toulouse | University Toulouse Hospital
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2000Last known activity
Nov 1, 2025
Timeline
1220s
- Jan 1, 1229
University of Toulouse— Founded
Drugs by trial phase (243 distinct, 258 trials)
Phase 4 (64 own, 0 via acquisition)
Phase 3 (74 own, 0 via acquisition)
Phase 2 (53 own, 0 via acquisition)
Phase 1 (28 own, 0 via acquisition)
Other trials (24 own, 0 via acquisition)
- 18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose
- Fluoroethyl-L-tyrosine
- apolipoprotein
- fatty acid-binding protein
- fluoroestradiol
- fluorodopa
- folic acid
- albumin (Human)
- cobalamin
- leucine
- levocarnitine
- polysulfone
- hepatitis b vaccine (recombinant)
- sulfur hexafluoride lipid-type a microspheres
- autologous bone marrow derived mesenchymal cells
- +9 more
Indications
Studied for
- Acute Coronary Syndrome
- Acute Pain
- Adenocarcinoma
- Adenomyosis
- Alzheimer Disease
- Amyloidosis
- Amyotrophic Lateral Sclerosis
- Anemia
- Arteritis
- Arthritis
- Arthritis, Rheumatoid
- Ascites
- Atherosclerosis
- Atrophy
- Autistic Disorder
- Autoimmune Diseases
- Azotemia
- Blood Coagulation Disorders
- Botulism
- Brain Death
- Brain Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Ischemia
- Brain Neoplasms
- Breast Neoplasms
- Brugada Syndrome
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cardiomyopathies
- Cardiovascular Diseases
- Cat-Scratch Disease
- Cerebral Infarction
- Cognitive Dysfunction
- Colorectal Neoplasms
- Communicable Diseases
- Congenital Abnormalities
- Coronary Artery Disease
- Cystic Fibrosis
- Darier Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Disease
- Disease Progression
- Dyskinesias
- Eclampsia
- Eczema
- Embolism
- Embolism, Cholesterol
- Emergencies
- Encephalitis
- Endocarditis
- Endocarditis, Bacterial
- Epidermolysis Bullosa
- Epidermolysis Bullosa Simplex
- Esophageal Neoplasms
- Fetal Growth Retardation
- Fibrosis
- Fragile X Syndrome
- Genital Neoplasms, Male
- Giant Cell Arteritis
- Glioblastoma
- Graft vs Host Disease
- Heart Failure
- Hemolysis
- Hemolytic-Uremic Syndrome
- Hemorrhage
- Hemostatic Disorders
- Hypotension
- Hypotension, Orthostatic
- Hypoxia-Ischemia, Brain
- Immune System Diseases
- Infections
- Inflammation
- Insulin Resistance
- Ischemia
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lichen Planus
- Lichen Planus, Oral
- Lung Diseases
- Lung Diseases, Interstitial
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphadenitis
- Lymphoma
- Lymphoma, B-Cell
- Mastocytosis
- Mastocytosis, Systemic
- Medulloblastoma
- Melanoma
- Memory Disorders
Recent trials (50)
- NCT07099534Lead sponsorPhase 2Nov 1, 2025
- NCT07048860Lead sponsorN/AJul 9, 2025
- NCT06817200Lead sponsorPhase 2May 1, 2025
- NCT06767150Lead sponsorPhase 4Mar 31, 2025
- NCT06795620Lead sponsorPhase 1Jan 31, 2025
- NCT06687551Lead sponsorPhase 4Jan 1, 2025
- NCT06690632Lead sponsorN/ADec 1, 2024
- NCT06636032Lead sponsorPhase 1/Phase 2Nov 30, 2024
- NCT06263816CollaboratorPhase 3Nov 15, 2024
- NCT06524583CollaboratorPhase 2Oct 31, 2024
- NCT06642844CollaboratorPhase 3Oct 30, 2024
- NCT06557889Lead sponsorPhase 2Oct 21, 2024
- NCT06527235Lead sponsorPhase 3Oct 1, 2024
- NCT06527235OfficialPhase 3Oct 1, 2024
- NCT06362447Lead sponsorPhase 2Sep 30, 2024
Details
- Founded
- Toulouse, FR Jan 1, 1229
- Last known activity
- Nov 1, 2025